Aspira Women's Health Past Earnings Performance
Past criteria checks 0/6
Aspira Women's HealthDie Erträge des Sektors -16.9% sind im Durchschnitt pro Jahr zurückgegangen, während die Erträge des Sektors Medical Equipment growing auf 9.1% pro Jahr stiegen. Die Einnahmen sind growing mit einer durchschnittlichen Rate von 22.3% pro Jahr gesunken.
Key information
-14.0%
Earnings growth rate
-4.7%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 21.4% |
| Return on equity | n/a |
| Net Margin | -182.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Aspira Women’s Health slips 23% on common stock offering
Aug 22Aspira Women’s Health GAAP EPS of -$0.07 in-line, revenue of $2.06M misses by $0.34M
Aug 10Is Aspira Women's Health (NASDAQ:AWH) Using Too Much Debt?
Aug 02
Is Aspira Women's Health (NASDAQ:AWH) Weighed On By Its Debt Load?
Apr 11Health Check: How Prudently Does Aspira Women's Health (NASDAQ:AWH) Use Debt?
Jan 07Aspira Women's Health (NASDAQ:AWH) Has Debt But No Earnings; Should You Worry?
Sep 24Aspira Women's Health Inc.'s (NASDAQ:AWH) Intrinsic Value Is Potentially 69% Above Its Share Price
Jul 06This Is Why Aspira Women's Health Inc.'s (NASDAQ:AWH) CEO Can Expect A Bump Up In Their Pay Packet
Jun 15Does Aspira Women's Health (NASDAQ:AWH) Have A Healthy Balance Sheet?
May 19A Look At The Fair Value Of Aspira Women's Health Inc. (NASDAQ:AWH)
Mar 28How Much Are Aspira Women's Health Inc. (NASDAQ:AWH) Insiders Spending On Buying Shares?
Feb 21Revenue & Expenses BreakdownBeta
How Aspira Women's Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 9 | -17 | 20 | 4 |
| 30 Sep 23 | 9 | -18 | 21 | 4 |
| 30 Jun 23 | 9 | -18 | 25 | 5 |
| 31 Mar 23 | 9 | -24 | 28 | 6 |
| 31 Dec 22 | 8 | -30 | 30 | 6 |
| 30 Sep 22 | 8 | -34 | 33 | 6 |
| 30 Jun 22 | 7 | -36 | 34 | 6 |
| 31 Mar 22 | 7 | -35 | 34 | 6 |
| 31 Dec 21 | 7 | -32 | 30 | 5 |
| 30 Sep 21 | 6 | -29 | 27 | 5 |
| 30 Jun 21 | 6 | -23 | 23 | 4 |
| 31 Mar 21 | 5 | -20 | 19 | 3 |
| 31 Dec 20 | 5 | -18 | 17 | 2 |
| 30 Sep 20 | 5 | -15 | 15 | 2 |
| 30 Jun 20 | 5 | -15 | 15 | 1 |
| 31 Mar 20 | 5 | -15 | 16 | 1 |
| 31 Dec 19 | 5 | -15 | 15 | 1 |
| 30 Sep 19 | 4 | -15 | 15 | 1 |
| 30 Jun 19 | 4 | -14 | 13 | 1 |
| 31 Mar 19 | 3 | -12 | 12 | 1 |
| 31 Dec 18 | 3 | -11 | 11 | 1 |
| 30 Sep 18 | 3 | -12 | 11 | 1 |
| 30 Jun 18 | 3 | -12 | 10 | 1 |
| 31 Mar 18 | 3 | -12 | 10 | 1 |
| 31 Dec 17 | 3 | -11 | 10 | 1 |
| 30 Sep 17 | 3 | -11 | 10 | 1 |
| 30 Jun 17 | 3 | -11 | 10 | 1 |
| 31 Mar 17 | 3 | -13 | 11 | 1 |
| 31 Dec 16 | 3 | -15 | 13 | 2 |
| 30 Sep 16 | 2 | -17 | 14 | 3 |
| 30 Jun 16 | 2 | -19 | 15 | 3 |
| 31 Mar 16 | 2 | -20 | 16 | 4 |
| 31 Dec 15 | 2 | -19 | 15 | 4 |
| 30 Sep 15 | 3 | -18 | 15 | 4 |
| 30 Jun 15 | 3 | -19 | 16 | 4 |
| 31 Mar 15 | 3 | -19 | 16 | 5 |
| 31 Dec 14 | 3 | -19 | 16 | 5 |
| 30 Sep 14 | 3 | -17 | 14 | 4 |
| 30 Jun 14 | 3 | -14 | 12 | 4 |
| 31 Mar 14 | 3 | -10 | 9 | 3 |
| 31 Dec 13 | 3 | -9 | 9 | 3 |
| 30 Sep 13 | 2 | -8 | 8 | 2 |
| 30 Jun 13 | 2 | -8 | 8 | 2 |
Qualität der Erträge: AWH ist derzeit unrentabel.
Wachsende Gewinnspanne: AWH ist derzeit unrentabel.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Ergebnisentwicklung: AWH ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 16.9% pro Jahr zugenommen.
Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von AWH verglichen werden, da das Unternehmen derzeit nicht profitabel ist.
Erträge im Vergleich zur Industrie: AWH ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Medical Equipment (3.7%) erschwert.
Return on Equity
Hohe Eigenkapitalrendite: AWHDie Verbindlichkeiten des Unternehmens übersteigen seine Vermögenswerte, so dass es schwierig ist, seine Eigenkapitalrendite zu berechnen.